Crossmark

Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controls

Crossref DOI link: https://doi.org/10.1186/s40170-022-00294-9

Published Online: 2022-10-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Julian O. http://orcid.org/0000-0003-0332-2024
Balshaw, Robert

Trevena, Connel

Banerji, Shantanu

Murphy, Leigh

Dawe, David

Tan, Lawrence

Srinathan, Sadeesh

Buduhan, Gordon

Kidane, Biniam

Qing, Gefei

Domaratzki, Michael

Aliani, Michel
Funding

Funding for this research was provided by:

Institute of Cancer Research (151566)
License Information

Text and Data Mining valid from 2022-10-12

Version of Record valid from 2022-10-12
More Information

Article History

Received: 27 September 2021

Accepted: 22 September 2022

First Online: 12 October 2022

Declarations

:

: This study was conducted with written approval from the University of Manitoba Health Research Ethics Board (HS19421) and the St. Boniface Hospital Research Review Committee (RRC/2016/1553).

: N/A

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below